Work

Phase II Biologic Effects Trial of Recombinant Interleukin-11 (rhIL-11, Neumega) in Moderate or Mild Hemophilia A or Von Willebrand Disease Unable to Use DDAVP,

Year: 2011

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v118.21.3308.3308

Authors: Margaret V. Ragni, Enrico M. Novelli, Anila Murshed, Elizabeth P. Merricks, Mark T. Kloos, Timothy C. Nichols

Institutions: University of Pittsburgh, Hemophilia Center of Western Pennsylvania, University of North Carolina at Chapel Hill

Language: English

Topic: Hemophilia Treatment and Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2571121807

FWCI:

Cites:

Cited by:

Related to: 10